Cite
HARVARD Citation
Park, B. et al. (2019). A bivalent fusion vaccine composed of recombinant Apx proteins shows strong protection against Actinobacillus pleuroneumoniae serovar 1 and 2 in a mouse model. Pathogens and disease. 77 (2), p. . [Online].